Magellan Healthcare and Concert Genetics recently collaborated to offer an innovative, end-to-end solution that delivers efficient management, improved quality, and accurate payment in genetic...
Tempus recently collaborated with the United States Department of Veterans Affairs (VA) National Precision Oncology Program (NPOP) to expand access to next-generation sequencing offerings and support...
Pfizer will open the first United States sites in the Phase 3 study evaluating its investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory patients with Duchenne...
The price of healthcare costs attributed to climate change and fossil fuel use is nearly $820 billion annually in the United States, according to multiple scientific research studies.
Over...
Wisconsin health authorities are investigating four cases of childhood hepatitis, including one patient who needed a liver transplant and one who died after suffering severe liver damage, according to...
The World Health Organization’s (WHOs) Strategic Advisory Group of Experts on Immunization (SAGE) recently concluded that a single-dose human papillomavirus (HPV) vaccine provides comparable...
A major international study recently identified 75 genes associated with an increased risk of developing Alzheimer's disease, including 42 new genes not previously discovered.
The study...
Mount Sinai scientists recently developed CRISPR technology to link genes to complex tumor characteristics at a scale and resolution not previously possible.
Perturb-map CRISPR technology uses a...
BioMarin Pharmaceuticals recently announced results from the Phase 3 GENEr8-1 study of valoctocogene roxaparvovec, an investigational gene therapy to treat adults with severe hemophilia...
Medtronic recently confirmed the effectiveness of its medical device, GI Genius intelligent endoscopy module, which uses artificial intelligence (AI) to detect colorectal polyps during...
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium (GTC), and Oxford Biomedica (OXB) will further accelerate the development of a potential new treatment option for patients with...
Inscripta recently granted a non-exclusive license to Hunterian Medicine, a gene-editing and gene therapy company, to access one of several CRISPR nucleases in its Madagascar family of nucleases...
Thermo Fisher Scientific recently launched a GMP-manufactured cell culture medium that supports the large-scale growth and culture of functional natural killer (NK) cells for cell and gene...
bluebird bio recently announced the completion of its rolling submission of its Biologics License Application to FDA for betibeglogene autotemcel (beti-cel) gene therapy in patients with...
Novartis recently acquired Arctos Medical to add a pre-clinical optogenetics-based AAV gene therapy program and Arctos’ proprietary technology to its ophthalmology portfolio.
Optogenetics has...
FDA recently cleared Neurogene’s Investigational New Drug (IND) application for its CLN5 Batten disease gene therapy, NGN-101.
NGN-101 is an adeno-associated virus (AAV) gene therapy and...
FDA recently placed a clinical hold on BioMarin Pharmaceuticals Phase 1/2 trial evaluating its AAV5-phenylalanine hydroxylase (PAH) gene therapy in adults with the rare disease, phenylketonuria...
NeuExcell Therapeutics and Spark Therapeutics recently announced a gene therapy collaboration to develop a safe and effective treatment for patients with Huntington’s Disease (HD).
Under...
